{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:40:22Z","timestamp":1793209222604,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jconrel.2023.04.011","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T17:36:25Z","timestamp":1682098585000},"page":"531-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation"],"prefix":"10.1016","volume":"357","author":[{"given":"Zili","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Schomann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferry","family":"Ossendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"ten Dijke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.04.011_bb0005","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"2004","key":"10.1016\/j.jconrel.2023.04.011_bb0010","first-page":"197","article-title":"Immunotherapy: bewitched, bothered, and bewildered no more","volume":"305","author":"Steinman","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.04.011_bb0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2016.25","article-title":"The future of cancer treatment: immunomodulation, CARs and combination immunotherapy","volume":"13","author":"Khalil","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0025","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0030","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.21.01497","article-title":"First-line immunotherapy for non\u2013small-cell lung Cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0035","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41565-022-01134-z","article-title":"Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles","volume":"17","author":"Li","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007576","article-title":"Harnessing innate immunity using biomaterials for Cancer immunotherapy","volume":"33","author":"Lee","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01250-1","article-title":"Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy","volume":"19","author":"Zheng","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2023.04.011_bb0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The cytosolic DNA-sensing cGAS\u2013sting pathway in cancer","volume":"10","author":"Won","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0060","article-title":"The STING1 network regulates autophagy and cell death","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0065","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1158\/1078-0432.CCR-17-2807","article-title":"Mitigating SOX2-potentiated immune escape of head and neck squamous cell carcinoma with a STING-inducing nanosatellite vaccine","volume":"24","author":"Tan","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005627","article-title":"STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer","volume":"11","author":"Ding","year":"2023","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000282","article-title":"Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma","volume":"8","author":"Wang-Bishop","year":"2020","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0080","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1021\/acs.nanolett.9b04094","article-title":"Synthetic immunogenic cell death mediated by intracellular delivery of STING agonist Nanoshells enhances anticancer chemo-immunotherapy","volume":"20","author":"Chattopadhyay","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627932","article-title":"Cancer vaccines, adjuvants, and delivery systems","volume":"12","author":"Paston","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0090","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2117321","article-title":"Targeting DNA damage response components induces enhanced STING-dependent type-I IFN response in ATM deficient cancer cells and drives dendritic cell activation","volume":"11","author":"Lopez-Pelaez","year":"2022","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2022.103409","article-title":"The DNA damage induced immune response: implications for cancer therapy","volume":"120","author":"Barros","year":"2022","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.jconrel.2023.04.011_bb0100","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001714","article-title":"Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer","volume":"8","author":"Arai","year":"2020","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0110","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.biomaterials.2016.01.006","article-title":"Combinatorial prospects of nano-targeted chemoimmunotherapy","volume":"83","author":"da Silva","year":"2016","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0115","author":"Woynarowski"},{"key":"10.1016\/j.jconrel.2023.04.011_bb0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0006-2952(03)00260-0","article-title":"DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells","volume":"66","author":"Faivre","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101202","article-title":"Macrophage polarization synergizes with oxaliplatin in lung cancer immunotherapy via enhanced tumor cell phagocytosis","volume":"14","author":"Li","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0130","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1118599","article-title":"Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression","volume":"5","author":"Ma","year":"2016","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0135","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12111054","article-title":"Liposome-based drug delivery systems in cancer immunotherapy","volume":"12","author":"Gu","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0145","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jconrel.2022.11.049","article-title":"Effective combination of liposome-targeted chemotherapy and PD-L1 blockade of murine colon cancer","volume":"353","author":"Gu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.04.011_bb0150","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jconrel.2022.11.049","article-title":"Effective combination of liposome-targeted chemotherapy and PD-L1 blockade of murine colon cancer","volume":"353","author":"Gu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.04.011_bb0155","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1021\/acs.langmuir.0c00475","article-title":"Mechanical properties determination of DMPC, DPPC, DSPC, and HSPC solid-ordered bilayers","volume":"36","author":"Drabik","year":"2020","journal-title":"Langmuir."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0160","first-page":"1308","article-title":"Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: a platform for investigating early endosomal events","volume":"2015","author":"Majzoub","year":"1848","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0165","author":"Duzgunes"},{"key":"10.1016\/j.jconrel.2023.04.011_bb0170","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1096\/fj.09-145755","article-title":"Uptake and trafficking of liposomes to the endoplasmic reticulum","volume":"24","author":"Pollock","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0175","first-page":"436","article-title":"The interplay of immunotherapy and chemotherapy: harnessing potential synergies, Cancer","volume":"3","author":"Emens","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0180","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological effects of conventional chemotherapy and targeted anticancer agents","volume":"28","author":"Galluzzi","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2023.04.011_bb0185","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3892\/ijo.2018.4661","article-title":"From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (review)","volume":"54","author":"Schirrmacher","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0190","series-title":"IL-12 Produced by Dendritic Cells Augments CD8+ T Cell Activation through the Production of the Chemokines CCL1 and CCL17 1","author":"Henry","year":"2022"},{"key":"10.1016\/j.jconrel.2023.04.011_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2011.00031","article-title":"Chemokines: a new dendritic cell signal fort cell activation","volume":"2","author":"Thaiss","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.697964","article-title":"Immunogenic cell death-based Cancer vaccines","volume":"12","author":"Jin","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.67","article-title":"Interferon-\u03b3 derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity","volume":"8","author":"Bhat","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0210","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.it.2017.04.002","article-title":"Mechanisms and dynamics of T cell-mediated cytotoxicity in vivo","volume":"38","author":"Halle","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0215","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.4049\/jimmunol.167.10.5574","article-title":"Regulation of IFN-\u03b3 signaling is essential for the cytotoxic activity of CD8+ T cells","volume":"167","author":"Tau","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0220","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of Interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0225","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.cell.2018.09.030","article-title":"High-dimensional analysis delineates myeloid and lymphoid compartment remodeling during successful immune-checkpoint cancer therapy","volume":"175","author":"Gubin","year":"2018","journal-title":"Cell."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0230","first-page":"313","article-title":"The emerging understanding of myeloid cells as partners and targets in tumor rejection, Cancer","volume":"3","author":"Broz","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0235","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0240","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age review-article","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0245","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.04.011_bb0250","doi-asserted-by":"crossref","first-page":"E10672","DOI":"10.1073\/pnas.1810580115","article-title":"Identification and validation of a tumor-infiltrating Treg transcriptional signature conserved across species and tumor types","volume":"115","author":"Magnuson","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923002614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923002614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:43:34Z","timestamp":1759164214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923002614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":50,"alternative-id":["S0168365923002614"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.011","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Leiden University Medical Center. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}